Iterum Therapeutics plc (ITRMF) Revenue (2017 - 2025)

Iterum Therapeutics (ITRMF) posted quarterly Revenue of $390000.0 for Q3 2025, up 954.05% on a QoQ basis from $37000.0 in Q1 2019.

Iterum Therapeutics plc (ITRMF) Revenue (2017 - 2025) Analysis & Trends

Iterum Therapeutics (ITRMF) has reported Revenue for 4 consecutive years, with $390000.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Revenue changed N/A year-over-year to $390000.0; the TTM figure through Sep 2025 stood at $390000.0 (changed N/A YoY), while the FY2019 annual figure was $37000.0, down 95.74% from the prior year.
Revenue came in at $390000.0 for Q3 2025 at Iterum Therapeutics, up from $37000.0 in the prior quarter.
The five-year high for Revenue was $390000.0 in Q3 2025, with the low at $390000.0 in Q3 2025.

Download Data